Records 1-30 (of 38 Records) |
Query Trace: Atrial fibrillation[original query] |
---|
Genetic risk, adherence to healthy lifestyle and acute cardiovascular and thromboembolic complications following SARS-COV-2 infection. Xie Junqing, et al. Nature communications 2023 0 0. (1) 4659 |
Incidence of arrhythmias in COVID-19 patients with double mutant strain of SARS-CoV-2 virus: A tertiary care experience. Varshney Amit, et al. Global cardiology science & practice 2023 0 0. (3) e202216 |
Genome Reporting for Healthy Populations-Pipeline for Genomic Screening from the GENCOV COVID-19 Study. Frangione Erika, et al. Current protocols 2022 0 0. (10) e534 |
Predictive model for severe COVID-19 using SARS-CoV-2 whole-genome sequencing and electronic health record data, March 2020-May 2021. Zhu Lei, et al. PloS one 2022 0 0. (7) e0271381 |
International electronic health record-derived post-acute sequelae profiles of COVID-19 patients HG Zhang et al, NPJ Digital Medicine, June 29, 2022
We leveraged electronic health record (EHR) data from 277 international hospitals representing 414,602 patients with COVID-19, 2.3 million control patients without COVID-19 in the inpatient and outpatient settings, and over 221 million diagnosis codes to systematically identify new-onset conditions enriched among patients with COVID-19 during the post-acute period. Compared to inpatient controls, inpatient COVID-19 cases were at significant risk for angina pectoris (RR 1.30, 95% CI 1.09–1.55), heart failure (RR 1.22, 95% CI 1.10–1.35), cognitive dysfunctions (RR 1.18, 95% CI 1.07–1.31), and fatigue (RR 1.18, 95% CI 1.07–1.30). Relative to outpatient controls, outpatient COVID-19 cases were at risk for pulmonary embolism (RR 2.10, 95% CI 1.58–2.76), venous embolism (RR 1.34, 95% CI 1.17–1.54), atrial fibrillation (RR 1.30, 95% CI 1.13–1.50), type 2 diabetes (RR 1.26, 95% CI 1.16–1.36) and vitamin D deficiency (RR 1.19, 95% CI 1.09–1.30).
|
Vulnerability of β-Thalassemia Heterozygotes to COVID-19: Results from a Cohort Study. Sotiriou Sotirios, et al. Journal of personalized medicine 2022 0 0. (3) |
Vaccine hesitancy in the post-vaccination COVID-19 era: a machine learning and statistical analysis driven study. Gupta Himanshu, et al. Evolutionary intelligence 2022 0 0. 1-19 |
SARS-CoV-2 attacks the weakest point - COVID-19 course in a pediatric patient with Friedreich's ataxia. Faltin Kamil, et al. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2022 0 0. |
Colchicine Against SARS-CoV-2 Infection: What is the Evidence? Drosos Alexandros A, et al. Rheumatology and therapy 2022 0 0. |
Causal associations between COVID-19 and atrial fibrillation: A bidirectional Mendelian randomization study. Zhang Xiaoyu, et al. Nutrition, metabolism, and cardiovascular diseases : NMCD 2022 0 0. |
Predictors of Venous Thromboembolism in COVID-19 Patients: Results of the COVID-19 Brazilian Registry Silveira, Warley C et al. Research Square January 06 2022 |
Wearable technology to inform the prediction and diagnosis of cardiorespiratory events: a scoping review. Khundaqji Hamzeh, et al. PeerJ 2022 0 0. e12598 |
The importance of association of comorbidities on COVID-19 outcomes: a machine learning approach. Arévalo-Lorido José Carlos, et al. Current medical research and opinion 2022 0 0. 1-32 |
COVID-19 in Adults With Hypertrophic Cardiomyopathy. Arabadjian Milla E, et al. Frontiers in cardiovascular medicine 2021 0 0. 745790 |
Colchicine-new horizons for an ancient drug. Schattner Ami, et al. European journal of internal medicine 2021 0 0. |
Uncovering Clinical Risk Factors and Predicting Severe COVID-19 Cases Using UK Biobank Data: Machine Learning Approach. Wong Kenneth Chi-Yin, et al. JMIR public health and surveillance 2021 0 0. (9) e29544 |
Application of artificial intelligence to the electrocardiogram. Attia Zachi I, et al. European heart journal 2021 0 0. |
Susceptibility of β-Thalassemia Heterozygotes to COVID-19. Sotiriou Sotirios, et al. Journal of clinical medicine 2021 0 0. (16) |
Rurality and atrial fibrillation: a pathway to virtual engagement and clinical trial recruitment in response to COVID-19. Magnani Jared W, et al. American heart journal plus : cardiology research and practice 2021 0 0. |
SARS-CoV-2 infection and acute ischemic stroke in Lombardy, Italy. Pezzini Alessandro, et al. Journal of neurology 2021 0 0. |
Incident atrial fibrillation and its risk prediction in patients developing COVID-19: A machine learning based algorithm approach. Lip Gregory Y H, et al. European journal of internal medicine 2021 0 0. |
Telemedicine for adult congenital heart disease patients during the first wave of COVID-19 era: a single center experience. Grandinetti Maria, et al. Journal of cardiovascular medicine (Hagerstown, Md.) 2021 0 0. |
SARS-CoV-2 Is a Culprit for Some, but Not All Acute Ischemic Strokes: A Report from the Multinational COVID-19 Stroke Study Group. Shahjouei Shima, et al. Journal of clinical medicine 2021 0 0. (5) |
Development of a multivariable prediction model for severe COVID-19 disease: a population-based study from Hong Kong. Zhou Jiandong et al. NPJ digital medicine 2021 4 (1) 66
The study developed a simple risk score for predicting severe COVID-19 disease using data based on simple clinical and laboratory variables. Consecutive patients admitted to Hong Kong?s public hospitals. The primary outcome was composite intensive care unit admission, need for intubation or death with follow-up until 8 September 2020. An external independent cohort from Wuhan was used for model validation.
|
Effect of a virtual self-management intervention for atrial fibrillation during the outbreak of COVID-19. Rosman Lindsey, et al. Pacing and clinical electrophysiology : PACE 2021 2 0. |
Atrial fibrillation is an independent predictor for in-hospital mortality in patients admitted with SARS-CoV-2 infection. Mountantonakis Stavros E, et al. Heart rhythm 2021 1 0. |
Changes in Cause-of-Death Attribution During the Covid-19 Pandemic: Association with Hospital Quality Metrics and Implications for Future Research Fairman, Kathleen A et al. medRxiv July 28 2020 |
Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation. Wallentin Lars, et al. European heart journal 2020 0 0. (41) 4037-4046 |
Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial. Sivapalan Pradeesh, et al. Trials 2020 0 0. (1) 513 |
Association of Troponin Levels With Mortality in Italian Patients Hospitalized With Coronavirus Disease 2019: Results of a Multicenter Study. Lombardi Carlo Mario, et al. JAMA cardiology 2020 0 0. (11) 1274-1280 |
Disclaimer: Articles listed in the Public Health
Knowledge Base are selected by the CDC Office of Public Health
Genomics to provide current awareness of the literature and news.
Inclusion in the update does not necessarily represent the views of
the Centers for Disease Control and Prevention nor does it imply
endorsement of the article's methods or findings. CDC and DHHS assume
no responsibility for the factual accuracy of the items presented. The
selection, omission, or content of items does not imply any
endorsement or other position taken by CDC or DHHS. Opinion, findings
and conclusions expressed by the original authors of items included in
the update, or persons quoted therein, are strictly their own and are
in no way meant to represent the opinion or views of CDC or DHHS.
References to publications, news sources, and non-CDC Websites are
provided solely for informational purposes and do not imply
endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:May 03, 2024
- Content source: